🇺🇸 Methohexitone in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anticholinergic Syndrome — 3 reports (23.08%)
  2. Apnoea — 3 reports (23.08%)
  3. Blood Pressure Decreased — 1 report (7.69%)
  4. Cardiac Arrest — 1 report (7.69%)
  5. Death — 1 report (7.69%)
  6. Dysarthria — 1 report (7.69%)
  7. Injection Site Pain — 1 report (7.69%)
  8. Loss Of Consciousness — 1 report (7.69%)
  9. Nodal Arrhythmia — 1 report (7.69%)

Source database →

Other Metabolic approved in United States

Frequently asked questions

Is Methohexitone approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Methohexitone in United States?

St Patrick's Hospital, Ireland is the originator. The local marketing authorisation holder may differ — check the official source linked above.